ALKERMES | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
ALKERMES USD 165.05M 163.25M 2025-06
Amgen USD 538M 33.04B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
J&J USD 3.12B 0 2025-03
Malin Corporation EUR 200K 0 2024-12
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 99M 0 2025-06
Otsuka Holdings JPY 528.13M 81.16B 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


ALKERMES Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.